Clinical Account Executive, Maine

Maine, United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Information TechnologyIndustries

Requirements

Candidates must possess advanced presentation skills and business acumen, with a strong understanding of molecular diagnostics for oncology and the evolving competitive landscape. Excellent knowledge of oncology, hematology, chemotherapeutics, and targeted agents is required, along with superior listening and problem-solving skills. Proficiency in Microsoft Office, particularly Excel and PowerPoint, and effective utilization of Salesforce.com are essential. The role demands the ability to work independently, communicate proactively, manage multiple projects, and prioritize tasks while meeting critical deadlines. A keen understanding of the payor and reimbursement environment in the oncology and diagnostic space is necessary, as is the ability to engage in consultative selling and sell at the executive level. Frequent travel (over 50%) throughout the territory is also required.

Responsibilities

The Clinical Account Executive will drive strategic business expansion and collaboration opportunities with major U.S. cancer centers, clinics, Key Opinion Leaders, and Academic Medical Centers within the assigned territory. Responsibilities include structuring detailed strategic plans for client acquisition and retention, maximizing client-bill contracting opportunities, and implementing laboratory services agreements. The role involves collaborating with sales positions to achieve company goals, identifying and developing partnering opportunities, and promoting compliance with new web-based molecular information tools. Additionally, the executive will analyze the competitive landscape, monitor sales performance, develop and implement a comprehensive business plan for the territory, and work effectively with individuals across multiple departments. Embracing and representing the Tempus company culture is also a key responsibility.

Skills

Precision Medicine

Healthcare Industry

AI in Clinical Care

Real-world Evidence

Strategic Business Expansion

Client Relationship Management

Contract Negotiation

Laboratory Services Agreements (LSA's)

Molecular Information Tools

Competitive Analysis

Business Planning

MolDx

SaaS Solutions

Sequencing Technology

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free